Patent · US Active

Treatment method utilizing pyrrolidine-2, 5-dione derivatives as IDO1 inhibitors

US10398679B2 · kind B2 · utility

1Cited by

3References

20Claims

0Family size

Assignee

iTeos Therapeutics SA · BE

Inventors

Stefano Crosignani · Nivelles, BE
Sandra Cauwenberghs · Halle, BE
Gregory Driessens · Ottignies, BE
Frederik Deroose · Gentbrugge, BE

Key dates

Filing date	Mar 23, 2018
Grant date	Sep 3, 2019
Priority date	—
Expiry date	Mar 23, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D403/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Uses of compound of Formula I: or pharmaceutically acceptable enantiomers, salts, solvates or prodrugs thereof are described. The compounds of Formula I are useful as IDO1 inhibitors. These are also useful for the treatment and/or prevention of cancer and endometriosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.